Exclusive Agreement with Largest Marketer and Distributor of Specialty Chemicals in Asia-Pacific to Power Regional Sales of Verdezyne’s BIOLON™ DDDA
CARLSBAD & SAN FRANCISCO, Calif. — March 8, 2016 —Verdezyne, Inc., a synthetic biology company producing biobased chemicals, and Connell Bros. Co. LLC (CBC), the largest marketer and distributor of specialty chemicals in the Asia-Pacific region, announced an agreement for sales and distribution of Verdezyne’s BIOLON™ DDDA (biobased dodecanedioic acid or “DC12”). BIOLON™ DDDA will be produced at Verdezyne’s commercial-scale plant in Malaysia and will be distributed in 17 countries throughout Asia-Pacific, including China, Japan and South Korea. The agreement assures CBC of access to more than 10% of the expected plant capacity.
Verdezyne’s BIOLON™ DDDA is produced more sustainably than traditional petroleum-derived intermediate chemicals and will be used to make a variety of end-user products including automotive parts, toothbrush bristles, cosmetics, and fragrances.
“This agreement with CBC reflects the strong interest in high-quality renewable chemicals such as our BIOLON™ DDDA,” said E. William Radany, Ph.D., president and CEO of Verdezyne. “As one of the largest and most respected distributors of specialty chemicals in the Asia-Pacific region, CBC is a strong partner for us. We are sure this agreement marks the beginning of a long and mutually-beneficial relationship.”
Verdezyne’s plant, expected to be completed in 2017, is anticipated to have the capacity to produce up to 9,000 metric tons of diacids including BIOLON™ DDDA annually.
“Verdezyne presented us with a very strong value proposition,” commented Scott Graddy, vice president, CBC. “We anticipate a strong demand for BIOLON™ DDDA from our customers in Asia-Pacific. We are very pleased to have reached this agreement with Verdezyne and we look forward to distributing BIOLON™ DDDA throughout the region.”
For samples, orders or more information about Verdezyne’s BIOLON™ DDDA, please contact:
- Asia: email@example.com
- Worldwide: firstname.lastname@example.org
Verdezyne is an industrial biotechnology company using proven and proprietary metabolic pathway engineering tools to develop unique yeast strains for cost-effective production of biobased chemicals. Current investors in Verdezyne include BP Alternative Energy Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby. For more information, visit www.verdezyne.com or connect with the company on Twitter, LinkedIn or Facebook.
About Connell Bros. Co.
Founded in 1895, Connell Bros. Co. LLC is one of the Wilbur-Ellis family of companies and is the largest marketer and distributor of specialty chemicals and ingredients in Asia-Pacific with a keen focus on technical service, customer support, and environmental, health, and safety. Connell Brothers provides complete supply chain management from transportation, documentation, warehousing, and sales and distribution in 17 countries and in 47 offices located throughout Asia-Pacific. For more information, please visit www.connellbrothers.com.
Corporate Communications, Verdezyne, Inc.
2715 Loker Avenue West
Carlsbad, CA 92010
Connell Bros. Co:
Hong Kong Media Contact:
+852 2969 2730
- Verdezyne Groundbreaking Ceremony in Malaysia Commemorates Initiation Of The World’s First Biobased DDDA Plant
- Verdezyne Launches New Corrosion Inhibitor
- Verdezyne Signs Distribution Agreement With Aceto Corporation
- Verdezyne Wins Presidential Green Chemistry Challenge Award
- Verdezyne Wins Bloomberg’s New Energy Pioneer Award